Shop

Author at Microdose

Microdose

At our core, we champion integrity, diversity, and objectivity, providing trusted content that unites a wide array of experts and fosters unbiased opinions, ultimately empowering the psychedelic medicine community to flourish and make a positive impact on the world.

Science

12 Apr 2023

Encyclopedia Psychedelica: What is LSD?

To help celebrate Bicycle Day coming up on April 19th (one of psychedelics’ unofficial birthdays), Microdose is devoting the month of April to an exploration of LSD....

By Microdose

Industry

23 Mar 2023

F.I.V.E. Clinical: Developing Standards of Care for 5-MeO-DMT

  “5-MeO DMT is the strongest psychedelic on the planet and has the very real potential to eclipse other psychedelics — but, if it’s not handled by people who know...

By Microdose

Industry

28 Feb 2023

Cultivating Psilocybin Consistency: A Deeper Look at Entheogen Biotech

Entheogen Biotech is a Canadian-based research and development biotech company, building an integrated approach towards modern mental health care, with a mushroom production and lab facility in Jamaica....

By Microdose

Culture

7 Feb 2023

Matthew Weintrub Sits Down with Microdose to Discuss the Psychedelic Origin of Religion

We welcome Matthew Weintrub, author of the newly released book, 'The Psychedelic Origin of Religion', for a Q&A session hosted by Microdose Psychedelics Insights....

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Industry

10 Jan 2023

Enthea Offers Access to Psychedelic Therapy With Health Insurance Plans

Enthea is a licensed, third-party administrator of health insurance benefits working to provide safe and affordable access to psychedelic-assisted psychotherapies....

By Microdose

Industry, Press Releases

5 Dec 2022

MY Self Ketamine Clinic Launches Ketamine Access Nonprofit

MY Self Wellness Ketamine Clinic Launches Nonprofit Organization Warriors of Consciousness, Helping Those Who Cannot Afford Psychedelic Ketamine Therapy Treatments...

By Microdose

Events, Industry

28 Nov 2022

The World on Drugs: Documentary Premiere at Wonderland

The World on Drugs is a documentary project produced by Microdose The filmmakers were joined by mushroom superstar Paul Stamets to discuss the film and its impact....

By Microdose

Events

23 Nov 2022

Wonderland 2022 Review: Ninnion Therapeutics

With Wonderland 2022 still fresh in our rear-view mirrors, let’s take a look at Ninnion Therapeutics, a Platinum Sponsor for Wonderland: Miami 2022....

By Microdose

Events

22 Nov 2022

Wonderland 2022 Recap: Mindstate Design Labs

With Wonderland 2022 still fresh in our rear-view mirrors, let's look at Mindstate Design Labs, a platinum sponsor for Wonderland: Miami 2022....

By Microdose

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

You Might Also Like

17 Dec 2025

Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward

If 2024 was the year the psychedelic field learned how hard “approval ready” really is, 2025 was the year it began behaving accordingly. The past twelve months were less about...

By Madison Roberts

26 Nov 2025

Delix Therapeutics Reports Strong Phase Ib Results

Delix Therapeutics recently announced compelling data from a Phase Ib trial of DLX-001 (zalsupindole), a non-hallucinogenic neuroplastogen. According to the company’s release, DLX-001 produced robust biomarker signals (quantitative EEG and...

By Madison Roberts

19 Nov 2025

Childhood Trauma’s Role in Men’s Substance Use Disorders

Childhood trauma leaves a deeper imprint on men’s lives than most realize—and for many, it becomes the hidden engine driving substance use disorders. Research shows that emotional abuse, physical violence,...

By Madison Roberts

19 Nov 2025

Human-Centered AI in Healthcare

Artificial intelligence is redefining modern healthcare, offering powerful tools that enhance diagnosis, expedite drug discovery, and enable truly personalized treatment. As health systems struggle with rising costs, aging populations, and...

By Madison Roberts

16 Oct 2025

Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up

As Big Pharma makes billion-dollar bets in the evolving landscape of neuropsychiatric therapeutics, Enveric Biosciences (NASDAQ: ENVB) is carving out a formidable position — not by chasing headlines, but by...

By Madison Roberts

15 Oct 2025

The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch

Take Enveric Biosciences (NASDAQ: ENVB), a company that’s been flying under the radar while building an IP fortress around a novel class of non-hallucinogenic neuroplastogens. Now, that fortress is being...

By Madison Roberts
WordPress Ads
No Result
View All Result

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.